Yescarta (axicabtagene ciloleucel) - Gilead
The efficacy of axi-cel in diffuse large B-cell lymphoma: evidence and implications for clinical practice (SIE 2026) - Oct 6, 2026 - Pres time: Sep 22, 2026; 01:30 PM - 03:30 PM; Location: HALL 2; "Supported by GILEAD SCIENCES." 
Clinical • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin's Lymphoma
https://manage.ercongressi.it/storage/ercongressi/article/pdf/285/14496-SIE2026%20-%20Programma.pdf
 
S. Sica; P.L. Zinzani
 
Oct 6, 2026
 
Prev Next